Zolmitriptan Nasal Spray: Defending Migraine Treatment Evidence

Research Summary

In the paper titled "Response to the Letter by Tfelt-Hansen and Hougaard" published in Cephalalgia, the authors address concerns raised about the evidence supporting the use of zolmitriptan nasal spray for treating migraine attacks. The letter from Tfelt-Hansen and Hougaard questioned the robustness of the data presented in the "Evidence-Based Recommendations of Pharmacological Treatment of Migraine Attacks." The authors of the response clarify and defend the methodologies and results that support zolmitriptan nasal spray as an effective treatment. They emphasize the reliability of their evidence, aiming to reaffirm confidence in its therapeutic use as outlined in the recommendations.

Study Details

📄 Title: Response to the Letter by Tfelt-Hansen and Hougaard "Some observed problems of the evidence presented for zolmitriptan nasal spray in the "Evidence-Based Recommendations of Pharmacological Treatment of Migraine Attacks".

👥 Research Team: Ornello R et al.

📚 Published In: Cephalalgia

📅 Publication Date: 2025 Nov

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.